Combined Treatment of Adipose Derived-Mesenchymal Stem Cells and Pregabalin Is Superior to Monotherapy for the Treatment of Neuropathic Pain in Rats
Aims. Neuropathic pain following nerve injury does not respond well to most available pharmacological remedies. We aimed to compare the outcome of the addition of adipose-derived mesenchymal stem cells (ADMSCs) to pregabalin for neuropathic pain treatment. Methods. Adult female albino rats (n=100) w...
Saved in:
| Main Authors: | Shimaa Mohammad Yousof, Doaa Attia ElSayed, Amani A. El-Baz, Hanaa S. Sallam, Faten Abbas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2021/8847110 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pregabalin (Lyrica™) - A new treatment option for neuropathic pain
by: Editorial Office
Published: (2008-06-01) -
Comparing the effectiveness of pregabalin and duloxetine in the management of neuropathic pain
by: Rojgar Hamed Ali, et al.
Published: (2025-04-01) -
A comparative study of the effectiveness and safety of pregabalin and duloxetine in the treatment of chemotherapy-induced neuropathic pain
by: Yogendra Singhal, et al.
Published: (2025-01-01) -
Pregabalin vs. gabapentin in the treatment of neuropathic pain: a comprehensive systematic review and meta-analysis of effectiveness and safety
by: Víctor Mayoral, et al.
Published: (2025-01-01) -
Macleaya Extract versus Pregabalin Therapeutic Effectiveness for Neuropathic Pain in Dogs
by: Saowanee Petchnamthong, et al.
Published: (2024-01-01)